Research Studies
Study Title
Lost in translation: Treatment Trials in the SOD1 Mouse and in Human ALS
Enrollment Status
Completed
Principal Investigators
Michael Benatar, MD, PhD
Study Type
Goals
Enrolling
Eligibility
Click to Expand
Study Involvement
Click to Expand
Contact
Links
Primary Funding Source
Related Publications
Click to Expand
Benatar M, Wuu J, Andersen PM, Atassi N, David W, Cudkowicz M, Schoenfeld D. Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS. Neurology. 2018 Feb 13;90(7):e565-e574. Epub 2018 Jan 24.
https://pubmed.ncbi.nlm.nih.gov/29367439
Schnabel J. Neuroscience: Standard model. Nature. 2008 Aug 7;454(7205):682-5.
https://pubmed.ncbi.nlm.nih.gov/18685674
Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis. 2007 Apr;26(1):1-13. Epub 2007 Jan 3.
Related Presentations & Lectures
Click to Expand
Benatar M (presenter), Wuu J, Atassi N, Cudkowicz M, Schoenfeld D. Randomized, phase II trial of arimoclomol in rapidly progressive SOD1 ALS. Late-breaking session platform presentation at the 27th International Symposium on ALS/MND, Dublin, Ireland, Dec 7-9, 2016.
Flinders University Center for Neuroscience Seminar. Adelaide, Australia, September 2015.
Benatar M (invited speaker). Challenges and Opportunities in ALS Therapy Development. Congress on Motor and Cognitive Degenerative Diseases. Yachay, Ecuador, January 2015.
Benatar M (invited speaker). ALS Therapy Development: Challenges and Opportunities. ALS Association Wisconsin Chapter. Milwaukee, WI, May 2014.
Benatar M (invited speaker). Predictive, Preventive and Therapeutic Studies in Familial ALS. ALS Association Annual Leadership Forum. Orange County, CA, January 2008.